Invivyd (IVVD) Accumulated Expenses (2020 - 2025)

Invivyd (IVVD) posted Accumulated Expenses of $19.1 million for Q4 2025, down 24.62% on a QoQ basis from $25.3 million in Q3 2025, and down 62.04% year-over-year from $50.2 million in Q4 2024.

Invivyd (IVVD) Accumulated Expenses (2020 - 2025) Analysis & Trends

Invivyd's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $19.1 million for Q4 2025.

  • Quarterly Accumulated Expenses fell 62.04% year-over-year to $19.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.1 million (down 62.04% YoY) and the FY2025 annual result came in at $19.1 million, down 62.04% from the prior year.
  • Accumulated Expenses was $19.1 million for Q4 2025 at Invivyd, down from $25.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $76.5 million in Q1 2022 and bottomed at $14.5 million in Q1 2023.
  • A 5-year average of $35.6 million and a median of $29.0 million in 2022 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2021 — Accumulated Expenses jumped 1044.07% — and 2023, when it slumped 81.05%.
  • Invivyd's Accumulated Expenses stood at $56.3 million in 2021, then plunged by 61.07% to $21.9 million in 2022, then jumped by 86.48% to $40.9 million in 2023, then gained by 22.85% to $50.2 million in 2024, then sank by 62.04% to $19.1 million in 2025.
  • Business Quant data shows IVVD's Accumulated Expenses at $19.1 million in Q4 2025, $25.3 million in Q3 2025, and $25.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 19.05 Mn
Sep 30, 2025 25.28 Mn
Jun 30, 2025 25.31 Mn
Mar 31, 2025 39.93 Mn
Dec 31, 2024 50.20 Mn
Sep 30, 2024 59.40 Mn
Jun 30, 2024 26.82 Mn
Mar 31, 2024 34.00 Mn
Dec 31, 2023 40.86 Mn
Sep 30, 2023 15.96 Mn
Jun 30, 2023 26.74 Mn
Mar 31, 2023 14.50 Mn
Dec 31, 2022 21.91 Mn
Sep 30, 2022 28.97 Mn
Jun 30, 2022 52.62 Mn
Mar 31, 2022 76.54 Mn
Dec 31, 2021 56.28 Mn
Sep 30, 2021 35.49 Mn
Jun 30, 2021 27.18 Mn
Dec 31, 2020 4.92 Mn